SARS-Cov-2 virus
UK :1st country to approve Omicron Vaccine
The United Kingdom has authorized the first ever covid-19 vaccine for Omicron variant. It is the first country to do so. Authorization of vaccine will now pave ways for autumn booster campaign using two-strain shot of Moderna. Highlights: Conditional authorisation ..
Month: Current Affairs - August, 2022
Category: International / World Current Affairs
IISc-CSIR Research to inactivate SARS-CoV-2
Researchers from Indian Institute of Science (IISc) recently conducted an experiment to inactivate the SARS-CoV-2 virus, in collaboration with the CSIR-Institute of Microbial Technology. Key Facts Researchers found the design of a new class of synthetic peptides. The peptides can ..
Month: Current Affairs - July, 2022
Category: Science & Technology Current Affairs
What is ‘TriSb92’ Molecule?
Researchers from University of Helsinki have developed a molecule, that can inactivate the coronavirus spike protein. It also offers effective short-term protection against the coronavirus. About TriSb92 Molecule Cell cultures and animal studies on TriSb92 molecule shows that, it protects ..
Month: Current Affairs - February, 2022
Category: Science & Technology Current Affairs
NeoCov Coronavirus
According to Chinese researchers, a type of coronavirus called NeoCov, which spreads among bats in South Africa is likely to pose threat to humans if it mutates further, in future. Highlights Study was posted on the preprint repository BioRxiv. However, it ..
Month: Current Affairs - January, 2022
Category: Science & Technology Current Affairs
IIT-D develops test to detect Omicron in 90 min
Researchers from IIT Delhi’s Kusuma School of Biological Sciences have developed an RT-PCR based test, that can detect Omicron variant of SARS-CoV-2 in 90 minutes. Key Points The test is based on detecting specific mutations, which are present in Omicron ..
Month: Current Affairs - December, 2021
WHO: Omicron Poses Very High Global Risk
On November 29, 2021, World Health Organization (WHO) warned that; the new variant of SARS-CoV-2 virus called “Omicron” poses very high global risk. Highlights Early evidence shows that, this highly mutated coronavirus could lead to surges with ‘severe consequences.’ It ..